bpc-157 and cancer risk Review: Doctor Explains Benefits, Safety & Do Peptides Increase Cancer Risk?
Description
Andrew Huberman raised a theoretical concern that BPC-157s angiogenic effects could be problematic in people with active or prior cancer risk, so caution is warranted in that group
Instead of passing through the gut only to be filtered out, intramuscular injections and IV drips infuse essential nutrients directly into your bloodstream, achieving 90% absorption
Liu YY, PhD, Professor, China S-Editor: Liu JH L-Editor: A P-Editor: Zhang L Contributor Information Himanshu Agrawal, Department of Surgery, University College of Medical Sciences (University of Delhi), GTB Hospital, Delhi 110095, India
Our medical team has worked with hundreds of first responders on peptide protocols
Schedule: Daily subcutaneous injections of the combined vial for 812 weeks, optionally extended to ~16 weeks
How long should a BPC-157 cycle last
